DOI : 10.1055/s-00000059

Pneumologie

Issue 07 · Volume 69 · July 2015 DOI: 10.1055/s-005-29517

4th DZL International Symposium “Frontiers in Chronic and Malignant Airways Disease”
2015 TLRC Lung Conference
Heidelberg, 25–27 June 2015

President: Marcus A. Mall
Abstracts (HTML) List of Authors
A1
Sommerburg, O; Stahl, M; Muckenthaler, M; Kohlmüller, D; Happich, M; Kulozik, AE; Hoffmann, GF; Mall, MA: Combining IRT/PAP+SN with DNA analysis for the best CF newborn screening strategy for Germany
A2
Gräber, S; Hug, M; Sommerburg, O; Hirtz, S; Hentschel, J; Heinzmann, A; Dopfer, C; Schulz, A; Mainz, J; Tümmler, B; Mall, MA: Intestinal Current Measurements Detect Activation of Mutant CFTR in Cystic Fibrosis Patients with the G551D Mutation Treated with Ivacaftor
A3
Agrawal, R; Altamura, S; Stanke, F; Meister, M; Muley, T; Randell, SH; Greene, CM; Tümmler, B; Muckenthaler, MU; Mall, MA: Dysregulation of epithelial miR-148b contributes to goblet cell metaplasia, inflammation and alveolar damage in cystic fibrosis lung disease
A4
Chillappagari, S; Garapati, V; Mahavadi, P; Stehling, O; Lill, R; Schmeck, B; Henke, M: MiR-210 and miR-155 are Upregulated in CFBE Cells and Involved in Fe-S Protein Assembly via ISCU Downregulation as well as HO-1 Expression via BACH1.
A5
Zhou-Suckow, Z; Fritzsching, B; Schatterny, J; Hirtz, S; Schmidt, S; Maier, E; Mall, MA: IL-1 receptor anatagonist anakinra reduces neutrophilic airway inflammation in mice with cystic fibrosis-like lung disease
A6
Albrecht, T; Salomon, J; Stichnoth, H; Baumann, I; Mall, MA: Regional differences in Cl- conductance in human nasal epithelial primary cells (hNEpC) of patients with chronic rhinosinusitis
A7
Salomon, JJ; Spahn, S; Wang, X; Füllekrug, J; Bertrand, CA; Mall, MA: Alternative chloride channels in cystic fibrosis (CF): Functional characterization of SLC26A9 in stably-overexpressing FRT epithelial cells
A8
Schubert, M; Merkert, S; Haase, A; Engels, L; Haller, R; Lachmann, N; Moritz, T; Tümmler, B; Galietta, L; Martin, U: Generation of disease-specific iPSCs and development of transgenic reporter cell lines for cystic fibrosis disease modelling and drug screening
A9
Wiehlmann, L; Chouvarine, P; Moran Losada, P; Tümmler, B: Normalization and calibration in the metagenomic analysis of CF lung microbiomes
A10
Wagner, C; Schatterny, J; Gehrig, S; Zhou-Suckow, Z; Schultz, C; Mall, MA: Small molecule inhibitor of neutrophil elastase reduces emphysema in mice with cystic fibrosis-like lung disease
A11
Hedtfeld, S; Pratap Singh Sandhu, S; Stanke, F; Tümmler, B; Munder, A: Hematopoetic Stem Cell Transplantation and Genotyping in Cystic Fibrosis Mouse Model
A12
Boutin, S; Stahl, M; Graeber, SY; Dittrich, S; Mall, MA; Dalpke, A: Longitudinal dynamics of cystic fibrosis airways' microbiota during clinical stability and exacerbation
A13
Boutin, S; Graeber, SY; Stahl, M; Dittrich, S; Mall, MA; Dalpke, A: Comparison of airways' microbiota at different sampling sites in patients with cystic fibrosis
A14
Dittrich, AS; Heath, N; Wiebel, M; Herth, FJ; Schultz, C; Mall, MA: Neutrophil elastase activity on the surface of sputum neutrophils is associated with severity of airflow obstruction in cystic fibrosis
A15
Seyhan Agircan, A; Lampe, M; Duerr, J; Pepperkok, R; Mall, MA: Development of Confocal Reflection Microscopy for the Study of Airway Surface Liquid Dysregulation in Cystic Fibrosis
A16
Rickert-Zacharias, V; Mall, MA; Schultz, C: Visualization of channel-activating protease (CAP) activity by peptide-based FRET probes